- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.09. | StoneX reiterates Buy on Prenetics stock, keeps $40 target | 1 | Investing.com | ||
| 08.09. | Prenetics Global Ltd - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 27.08. | B.Riley initiates Prenetics stock coverage with buy rating on IM8 growth | 4 | Investing.com | ||
| 27.08. | B.Riley stuft Prenetics Aktie mit "Buy" ein - Wachstum durch IM8 im Fokus | 1 | Investing.com Deutsch | ||
| PRENETICS GLOBAL Aktie jetzt für 0€ handeln | |||||
| 26.08. | Prenetics Global CEO and CFO purchase $1M of shares in open market | 2 | Seeking Alpha | ||
| 26.08. | Prenetics Global Limited: Prenetics' IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results | 2 | GlobeNewswire (USA) | ||
| 26.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 21.08. | Prenetics Global Ltd - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
| 20.08. | Prenetics Global Limited: Prenetics' IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership | 1 | GlobeNewswire (USA) | ||
| 18.08. | Prenetics Q2 2026 slides: cash flow turns positive, $1B deal fuels growth | 10 | Investing.com | ||
| 18.08. | Prenetics Global GAAP EPS of -$0.53 beats by $0.01, revenue of $46.5M misses by $2.68M | 2 | Seeking Alpha | ||
| 18.08. | Prenetics Global Limited: Prenetics' IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220-230 Million | 662 | GlobeNewswire (Europe) | Total revenue of $46.5 million, up ~288% YoY (~3.9x); within the Company's guidance of $46-48 millionIM8 revenue of $45.0 million, up ~359% YoY (~4.6x); within the Company's guidance of $44-46 million... ► Artikel lesen | |
| 17.08. | Prenetics Global Q2 2026 Earnings Preview | 5 | Seeking Alpha | ||
| 17.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.08. | Prenetics Global Ltd - F-1/A, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 07.08. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.07. | Prenetics Raises $1 Billion For IM8 Via General Catalyst's Customer Value Fund | 3 | pulse2.com | ||
| 14.07. | Prenetics Global Limited: Prenetics' IM8 Secures $1 Billion Growth Financing from General Catalyst's Customer Value Fund (CVF) | 4 | GlobeNewswire (USA) | ||
| 14.07. | Prenetics Global Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.06. | Prenetics Global Limited (PRE) Receives Bullish Coverage as IM8 Targets Supplement Market Growth | 1 | Insider Monkey |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | 685,10 | +0,53 % | Regeneron auf Morgan Stanley Konferenz: Wachstum stützt sich auf Dupixent | ||
| VIKING THERAPEUTICS | 25,100 | -0,59 % | Wall Street Sees a Huge Rebound for Viking Therapeutics. Here's Why Analysts Are So Optimistic. | ||
| GUARDANT HEALTH | 156,88 | +0,46 % | ARK Invest stockt Beteiligung an Guardant Health auf | ||
| CANSINO BIOLOGICS | 2,880 | 0,00 % | CANSINOBIO (06185): 2026 INTERIM REPORT | ||
| SINO BIOPHARM | 0,595 | -1,51 % | CHINARES PHARMA Subsidiary Forges Strategic Co-op With SBP GROUP | ||
| BIO-TECHNE | 63,10 | +0,03 % | Aktionärsklage zwingt Bio-Techne zu ergänzenden Angaben zur Merck-Fusion | ||
| INNOVENT BIOLOGICS | 10,896 | -0,51 % | Innovent Biologics: Innovent Announces 2026 Interim Results and Business Updates | Transforming from Regional Leader to Global Premier:
A Clear Strategic Path for Growth and Globalization
SAN FRANCISCO and SUZHOU, China, Aug. 25, 2026 /PRNewswire/... ► Artikel lesen | |
| GENSCRIPT BIOTECH | 4,240 | -0,47 % | HSI Closes at 24,750, Up 146 pts; HSTI Closes at 4,405, Up 94 pts; BABA Up over 3%; LENOVO GROUP, LIULIUMEI, LEGENDHOLDING, STAR SHINE HLDG, GENSCRIPT BIO Hit New Highs; Market Turnover Rises | ||
| QUANTUM-SI | 0,755 | +1,38 % | Quantum-Si Incorporated: Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus | BRANFORD, Conn., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics company redefining protein analysis through single-molecule... ► Artikel lesen | |
| AKESO | 10,175 | +1,60 % | Akeso, Inc.: Akeso's EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate | HONG KONG, Sept. 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that AK158D1, its investigational next-generation bispecific... ► Artikel lesen | |
| SCILEX | 4,360 | +1,87 % | Scilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026 | PALO ALTO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing, and... ► Artikel lesen | |
| ORIGIN AGRITECH | 0,835 | +1,83 % | Origin Agritech Ltd.: Origin Agritech Establishes R&D Center in Guizhou with Biotech Unit and State-Backed Seed Joint Venture | Wholly Owned Guizhou Origin and a 25%-Held Joint Venture with a State-Owned Seed Group Form a Full-Chain Research, Production, and Distribution Platform for Southwest China BEIJING, Aug. 31, 2026... ► Artikel lesen | |
| HARMONY BIOSCIENCES | 42,030 | +0,02 % | Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile | WAKIX® Net Revenue Grew 30% Year over Year to $261.3 Million for Second Quarter 2026; Estimated Average Patients Increased 450 to 8,950; Reiterates 2026 WAKIX Net Revenue Guidance of $1.0 Billion... ► Artikel lesen | |
| NIKI BIOSOLUTIONS | 4,950 | +4,87 % | Niki BioSolutions, Inc.: Niki BioSolutions Accelerates Its Alzheimer's Disease Testing Pipeline Through Strategic Bioinformatics and Statistical Analysis Partnership with Fios Genomics | Advanced multi-omics data analysis and biostatistical expertise to sharpen target and biomarker decisions across the platform PRINCETON, N.J., and NEW HAVEN, Conn., Sept. 14, 2026 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| HEMAB THERAPEUTICS | 41,190 | 0,00 % | Gubra A/S: Gubra collaboration partner Hemab announces first participant dosed in Phase 1 clinical trial of HMB-003, an investigational therapy for the management of heavy menstrual bleeding | Today, Gubra announced that its partner Hemab Therapeutics has dosed the first healthy volunteer in its Phase 1 clinical trial evaluating HMB-003, an investigational therapy for the management of heavy... ► Artikel lesen |
Das Unternehmen PRENETICS GLOBAL LIMITED kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,350 (+1,45 %) liegt der Kurs bei 24,540 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PRENETICS GLOBAL LIMITED finden Sie auf Wallstreet Online.